Tucker Asset Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Tucker Asset Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-29	Closed	-$742	–	1545
2024 Q3	$742	Sell	29 -38	-57%	-$968	﹤0.01%	1312
2024 Q2	$1.57K	Buy	67 +20	+43%	+$505	﹤0.01%	1371
2024 Q1	$1.35K	Hold	47	–	–	﹤0.01%	1383
2023 Q4	$1.54K	Hold	47	–	–	﹤0.01%	1176
2023 Q3	$1.31K	Buy	47 +13	+38%	+$425	﹤0.01%	1116
2023 Q2	$1.16K	Sell	34 -80	-70%	-$2.51K	﹤0.01%	953
2023 Q1	$3.43K	Sell	114 -27	-19%	-$837	﹤0.01%	781
2022 Q4	$3.97K	Hold	141	–	–	﹤0.01%	474
2022 Q3	$4.76K	Buy	+141	New	+$5.18K	﹤0.01%	439

Other funds holding ARKG

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Tucker Asset Management's ARKG Position: Q4 2024 in Review

Tucker Asset Management sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2024, closing a stake of 29 shares — an estimated $742 sold.

Tucker Asset Management first reported a position in ARKG in Q3 2022 and held it in 9 quarters. The position peaked at $4.76K in Q3 2022. 238 funds tracked by Wall St. Rank hold ARKG as of Q4 2024.

Tucker Asset Management reported no remaining ARK Genomic Revolution ETF position as of Q4 2024 after selling out during the quarter.
Tucker Asset Management sold 29 ARK Genomic Revolution ETF shares in Q4 2024, an estimated $742.
Tucker Asset Management first reported a position in ARK Genomic Revolution ETF in Q3 2022 and held it in 9 quarters.
Tucker Asset Management's ARK Genomic Revolution ETF position peaked at $4.76K in Q3 2022.
238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2024.

Based on Tucker Asset Management's 13F filing for Q4 2024, filed 12 Feb 2025.